SEC Tracker
Get the app
LLY · XBRL financial data

ELI LILLY and Company financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (LLY's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue9,353*8,76811,30311,43913,533*12,72915,55817,60119,292*19,79922,97424,397
Cost of goods and services sold1,788*1,6742,1702,1712,404*2,2242,4483,0083,372*3,5773,2683,933
Selling, general and administrative1,925*1,9522,1172,1002,425*2,4692,7532,7413,131*2,9343,4303,125
Interest income45*46374844*484065————
Interest expense138*180184193225*244249180223*———
Other income (expense)(22)*29(8)(21)(26)*(4)(101)(179)————
Income tax expense (benefit)319*293550618629*6971,1161,6501,629*1,4542,1521,955
Net income (loss)2,190*2,2432,9679704,410*2,7595,6615,5836,638*7,3967,0956,451
Earnings per share, basic USD per share2.43*2.493.291.084.90*3.076.306.227.41*8.277.957.23
Earnings per share, diluted USD per share2.41*2.483.281.074.88*3.066.296.217.39*8.267.947.22
Weighted average shares, basic millions of shares900*901901901900*899898897896*895892892
Weighted average shares, diluted millions of shares907*904904905903*901900899898*896894893

Balance sheet

CSV

Fiscal quarters (LLY's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents2,8192,4603,2243,3693,2683,0933,3769,7927,2685,2828,9504,885
Short-term investments109126140149155127170122————
Accounts receivable9,0917,88611,02810,29511,00612,03714,17016,10717,76018,42920,08322,089
Inventory5,7736,1026,4827,4607,5899,31111,01412,18013,74414,52916,79318,194
Total current assets25,72725,18930,20431,41532,74041,26149,85462,07155,62954,83564,67265,263
Property and equipment, net12,91413,62414,82916,17217,10218,47420,53022,31624,67526,54029,28632,188
Right-of-use asset1,024———1,050———1,260———
Goodwill4,9404,9405,7685,7685,7705,7715,7715,8985,8986,1308,8499,874
Total assets64,00663,94471,87575,60778,71589,389100,923114,935112,476116,576142,283148,072
Accounts payable2,5992,4742,9252,8873,2293,4424,0764,2625,3795,0296,1125,793
Commercial paper6,189———4,338———0———
Total current liabilities27,29318,59827,12124,67428,37730,06839,02040,14135,22836,63447,74146,996
Long-term debt18,32124,56023,73029,04528,52734,50034,18040,87440,86839,37047,85846,986
Lease liability, non-current949———971———1,140———
Retained earnings10,31212,55413,17813,62713,54515,10017,37622,25224,47029,51431,89337,969
Total stockholders' equity10,77212,81213,56214,24014,19215,76518,27323,79326,53531,19833,87940,271
Total liabilities and equity64,00663,94471,87575,60778,71589,389100,923114,935112,476116,576142,283148,072
Common shares outstanding (cover page) millions of shares950950950949948948946945943942941941

Cash flows

CSV

Fiscal quarters (LLY's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)2,190*2,2432,9679704,410*2,7595,6615,5836,638*7,3967,0956,451
Stock-based compensation120*159211*133*142*154185*151*136*161201*200*
Depreciation and amortization388*401414*467*485*463479*470*586*509534*545*
Net cash from operating activities(312)*1,1661,466*3,712*2,474*1,6663,087*8,836*3,225*5,33310,690*11,397*
Net cash from investing activities(2,924)*(1,178)(2,199)*(4,005)*(1,921)*(3,352)(1,835)*(2,983)*(2,802)*(3,916)(15,396)*(8,299)*
Share repurchases0*00*446*2,054*1,200692*708*1,508*2,3561,601*377*
Dividends paid1,018*1,1691,172*1,171*1,168*1,3461,347*1,345*1,346*1,5481,546*1,541*
Proceeds from long-term debt0*6,4530*4,965*0*6,4610*6,706*(0)*08,941*0*
Repayments of long-term debt0*——0*0*0778*0*(0)*750873*0*
Net cash from financing activities3,545*(311)1,556*211*(225)*1,380(1,245)*531*(2,879)*(3,470)8,426*(7,219)*
Net change in cash438*(358)763*145*(101)*(175)283*6,416*(2,524)*(1,986)3,668*(4,065)*

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Eli Lilly4,88524,39711,397*940.7M 10-QSep 30, 2026
Johnson & Johnson16,91025,3997,720*2.4B 10-QSep 27, 2026
AbbVie10,77417,4047,606*1.8B 10-QSep 30, 2026
Abbott Laboratories4,05213,0131,737*1.7B 10-QSep 30, 2026
Merck9,55018,0856,558*2.5B 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.